Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Towards Prodrug-Nanomedicine Design

Molecular Pharmaceutics - United States
doi 10.1021/acs.molpharmaceut.8b01257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Engineering a Prostate-Specific Membrane Antigen-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy

Science Translational Medicine
Medicine
2012English

Analysis of a Conjugate Between Anti-Carcinoembryonic Antigen Monoclonal Antibody and Alkaline Phosphatase for Specific Activation of the Prodrug Etoposide Phosphate

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
1992English

The Role of Adenoviral Vectors in Genetic Prodrug Activation Therapy in Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2000English

Towards Light Activated Ruthenium‐Arene (RAPTA‐type) Prodrug Candidates

ChemBioChem
Organic ChemistryBiochemistryMolecular MedicineMolecular Biology
2019English

A Colon-Specific Prodrug of Metoclopramide Ameliorates Colitis in an Experimental Rat Model

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Synthesis and Characterization of a Novel Prostate Cancer-Targeted Phosphatidylinositol-3-Kinase Inhibitor Prodrug

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2012English

Genetic Prodrug Activation in erbB-2 Overexpressing Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
1999English

Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin

Clinical Cancer Research
Cancer ResearchOncology
2008English

Design and Discovery of a Novel Dipeptidyl-Peptidase IV (CD26)-Based Prodrug Approach

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy